Rockwell Medical Technologies, Inc. (RMTI)

[FredKerx]

Competitors watching the “show” (they know what’s going on) along with the rest of the industry — CMS watching. Time of essence, the renal/iron deficiency space moving forward rapidly, providers waiting, patients waiting, meanwhile, a potential mess in the cards — IMO, all in the name of “a plan”, by “a plan”, for “a plan”, put in motion a while ago, so goes hypothetical.

Chioini, yes, self-serving bastad, but, IMO, the alternative is not “peaches and cream” either. What is the company and shareholders REALLY gaining from all this? Can anyone answer this question? Chioini/Klema terminated is not a viable answer, IMO. Why? — because,IMO, if Big Pharma wants the company and its technology then get the BOD and majority shareholders aligned (which are aligned anyway) and buy the damn thing for a reasonsble price, it’s not like the funds are not available. Why the hostility to take control of the company (IMO) as a prelude — what, a few T’s to cross and I’s to dot prior to end-game have we?

ALL above, in my opinion